Adage Capital Partners’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-150,000
Closed -$1.03M 1167
2022
Q1
$1.03M Hold
150,000
﹤0.01% 934
2021
Q4
$1.21M Sell
150,000
-250,000
-63% -$1.66M ﹤0.01% 892
2021
Q3
$2.46M Sell
400,000
-1,000,000
-71% -$3.79M ﹤0.01% 886
2021
Q2
$4.35M Hold
1,400,000
0.01% 839
2021
Q1
$5.38M Buy
+1,400,000
New +$5.31M 0.01% 789
2020
Q2
Sell
-600,000
Closed -$5.99M 812
2020
Q1
$5.99M Sell
600,000
-700,000
-54% -$6.24M 0.02% 552
2019
Q4
$9.88M Hold
1,300,000
0.02% 538
2019
Q3
$8.31M Buy
+1,300,000
New +$9.17M 0.02% 552

Other funds holding BLU

Adage Capital Partners's BLU Position: Q2 2022 in Review

Adage Capital Partners sold out of BELLUS Health Inc. (BLU) in Q2 2022, closing a stake of 150,000 shares — an estimated $1.03M sold.

Adage Capital Partners first reported a position in BLU in Q3 2019 and held it in 8 quarters. The position peaked at $9.88M in Q4 2019. 94 funds tracked by Wall St. Rank hold BLU as of Q2 2022.

  • Adage Capital Partners reported no remaining BELLUS Health Inc. position as of Q2 2022 after selling out during the quarter.
  • Adage Capital Partners sold 150,000 BELLUS Health Inc. shares in Q2 2022, an estimated $1.03M.
  • Adage Capital Partners first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 8 quarters.
  • Adage Capital Partners's BELLUS Health Inc. position peaked at $9.88M in Q4 2019.
  • 94 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2022.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.